Diagnostic Gleason Sums Often Wrong
Diagnostic gleason sums frequently differ from those determined by pathologic analysis of prostate biopsy specimens, a study shows. The discrepancies were due mostly to understaging.
Diagnostic gleason sums frequently differ from those determined by pathologic analysis of prostate biopsy specimens, a study shows. The discrepancies were due mostly to understaging.
MRI-guided biopsy of the prostate may improve the diagnostic accuracy in men with elevated or rising PSA levels following previous negative transrectal ultrasound (TRUS)-guided biopsies, German researchers report.
African-American (AA) men with nonpalpable prostate cancer have greater cancer volumes and higher prostatectomy Gleason scores than white men with similar PSA levels at the time of biopsy, according to a study.